Sivik Global Healthcare’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,000
| Closed | -$2.65M | – | 43 |
|
|
2022
Q4 | $2.65M | Sell |
15,000
-22,500
| -60% | -$3.98M | 1.25% | 35 |
|
|
2022
Q3 | $6.13M | Buy |
37,500
+12,500
| +50% | +$2.04M | 3.4% | 10 |
|
|
2022
Q2 | $4.44M | Sell |
25,000
-10,000
| -29% | -$1.78M | 2.52% | 18 |
|
|
2022
Q1 | $6.2M | Buy |
35,000
+5,000
| +17% | +$886K | 2.56% | 12 |
|
|
2021
Q4 | $5.13M | Sell |
30,000
-40,000
| -57% | -$6.84M | 2.2% | 24 |
|
|
2021
Q3 | $11.3M | Buy |
70,000
+15,000
| +27% | +$2.42M | 2.7% | 3 |
|
|
2021
Q2 | $9.06M | Buy |
55,000
+20,000
| +57% | +$3.29M | 1.77% | 12 |
|
|
2021
Q1 | $5.75M | Sell |
35,000
-30,000
| -46% | -$4.93M | 2.1% | 28 |
|
|
2020
Q4 | $10.2M | Buy |
65,000
+5,000
| +8% | +$787K | 4.17% | 1 |
|
|
2020
Q3 | $8.93M | Buy |
60,000
+30,000
| +100% | +$4.47M | 3.84% | 3 |
|
|
2020
Q2 | $4.22M | Buy |
+30,000
| New | +$4.22M | 1.4% | 32 |
|
|
2020
Q1 | – | Sell |
-35,000
| Closed | -$5.11M | – | 52 |
|
|
2019
Q4 | $5.11M | Buy |
+35,000
| New | +$5.11M | 1.9% | 31 |
|
|
2018
Q1 | – | Sell |
-30,000
| Closed | -$4.19M | – | 62 |
|
|
2017
Q4 | $4.19M | Buy |
+30,000
| New | +$4.19M | 1.56% | 29 |
|
|
2017
Q3 | – | Sell |
-70,000
| Closed | -$9.26M | – | 78 |
|
|
2017
Q2 | $9.26M | Buy |
+70,000
| New | +$9.26M | 3.39% | 3 |
|
|
2017
Q1 | – | Sell |
-35,000
| Closed | -$4.03M | – | 66 |
|
|
2016
Q4 | $4.03M | Sell |
35,000
-25,000
| -42% | -$2.88M | 1.92% | 23 |
|
|
2016
Q3 | $7.09M | Buy |
60,000
+20,000
| +50% | +$2.36M | 3.57% | 8 |
|
|
2016
Q2 | $4.85M | Buy |
+40,000
| New | +$4.85M | 2.41% | 12 |
|